Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles

Modern Pathology

Volumn 26, Issue 7, 2013, Pages 955-966

  Gazinska, Patrycja ^a,b   Grigoriadis, Anita ^a   Brown, John P ^b   Millis, Rosemary R ^b   Mera, Anca ^a,b   Gillett, Cheryl E ^b   Holmberg, Lars H ^a,b   Tutt, Andrew N ^a   Pinder, Sarah E ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

basal like phenotype; invasive breast cancer; triple negative breast cancer

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; COMPARATIVE STUDY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PREGNANCY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREGNANCY; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84879901369     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.244     Document Type: Article

References (31)

1. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938-1948.
2. Rakha E, Reis-Filho JS. Basal-like breast carcinoma: From expression profiling to routine practice. Arch Pathol Lab Med 2009;133:860-868.
3. Subhawong AP, Subhawong T, Nassar H, et al. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol 2009;33:163-175.
4. Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007;13:2329-2334. (Pubitemid 46698581)
5. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: A singleinstitution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 2007;110:876-884. (Pubitemid 47257667)
6. Brenton JD, Carey LA, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol 2005;23:7350-7360. (Pubitemid 46202348)
7. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-5374. (Pubitemid 39100473)
8. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-10874. (Pubitemid 32878711)
9. Fulford LG, Reis-Filho JS, Ryder K, et al. Basal-like grade III invasive ductal carcinoma of the breast: Patterns of metastasis and long-term survival. Breast Cancer Res 2007;9:R4.
10. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429-4434. (Pubitemid 47219710)
11. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-752.
12. Bertucci F, Finetti P, Cervera N, et al. How basal are triple-negative breast cancers? Int J Cancer 2008;123: 236-240. (Pubitemid 351705215)
13. Badve S, Dabbs DJ, Schnitt SJ, et al. Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 2011;24:157-167.
14. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: A critical review. J Clin Oncol 2008;26: 2568-2581.
15. Reis-Filho JS, Tutt AN. Triple negative tumours: A critical review. Histopathology 2008;52:108-118. (Pubitemid 350265179)
16. Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008;14:1368-1376. (Pubitemid 351413917)
17. Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer 2007; 109:25-32. (Pubitemid 46120191)
18. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 2006;19:264-271. (Pubitemid 43117611)
19. Haupt B, Ro JY, Schwartz MR. Basal-like breast carcinoma: A phenotypically distinct entity. Arch Pathol Lab Med 2010;134:130-133.
20. Da Silva L, Clarke C, Lakhani SR. Demystifying basallike breast carcinomas. J Clin Pathol 2007;60:1328-1332.
21. Putti TC, El-Rehim DM, Rakha EA, et al. Estrogen receptor-negative breast carcinomas: A review of morphology and immunophenotypical analysis. Mod Pathol 2005;18:26-35. (Pubitemid 40128091)
22. Winter J. Morphological and immunophenotypic analysis of basal-like carcinoma of the breast. Biosci Horiz 2008;1:19-27.
23. Ellis IO, Pinder SE, Bobrow L, et al. Pathology reporting of breast disease. NHSNBS 2005;58:1-144.
24. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481. (Pubitemid 29220854)
25. Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009;27:1160-1167.
26. Maiorano E, Regan MM, Viale G, et al. Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast Cancer Res Treat 2010;121:211-218.
27. Rakha EA, Martin S, Lee AH, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 2012;118: 3670-3680.
28. Liu S, Lachapelle J, Leung S, et al. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res 2012;14:R48.
29. Choi YL, Oh E, Park S, et al. Triple-negative, basal-like, and quintuple-negative breast cancers: Better prediction model for survival. BMC Cancer 2010;10:507.
30. Thike AA, Cheok PY, Jara-Lazaro AR, et al. Triplenegative breast cancer: Clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol 2010;23:123-133.
31. Jumppanen M, Gruvberger-Saal S, Kauraniemi P, et al. Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Res 2007;9:R16.